Skip to main content
. 2023 Jun 15;2023:9010753. doi: 10.1155/2023/9010753

Table 3.

Comparison of perioperative outcomes as median (IQR).

Control group ESP group P value∗∗
(n = 50) (n = 50)
Length of hospital stay (days, median (IQR)) 4 (3–5) 3 (2–5) 0.68

VAS a score postoperative (mg, median (IQR))
An admission to PACU 0 (0) 0 (0) 0.15
At 60 min 2 (2-3) 1 (1-2) <0.001
At 4 hoursb 4 (3-5) 2 (1-3) <0.001
At 8 hours 5 (4-5) 3 (2-3) <0.001
At 12 hours 5 (4.75–5.25) 2 (2-3) <0.001
At 24 hours 5 (4-5) 5 (5-6) <0.001
At 48 hours 3 (3-4) 4 (3-4) 0.01

Opioid postoperative treatment (mg, median (IQR))
An admission to PACU 10 (10-10) 10 (5–10) 0.002
At 60 min 10 (5–10) 5 (0–5) <0.001
At 4 hours 1 (0–3) 0 (0) <0.001
At 8 hours 1.5 (0–3) 0 (0–0.75) <0.001
At 12 hours 0 (0–3) 0 (0) 0.0017
At 24 hours 0 (0–0.75) 1.5 (0–3) 0.002
At 48 hours 0 (0) 0 (0) 0.15

Additional non-opioid postoperative analgesia c management (n, median (IQR))
At 4 hours 0 (0-1) 0 (0) <0.001
At 8 hours 1 (0-1) 0 (0-1) <0.001
At 12 hours 1 (0-1) 0 (0) <0.001
At 24 hours 0 (0-1) 1 (0-1) 0.159
At 48 hours 1 (0-1) 0 (0) <0.001

Control group: patients received standard pain control treatment; ESP group: patients received ESP block in addition to standard pain control treatment. ∗∗Data are considered statistically significant if p < 0.05. aVAS: Visual Analog Scale for pain assessment. bAt the regular general surgery ward. cNon-opioid postoperative analgesic management includes 125 mg IV tramadol + 1.25 g PO metamizole.